Slide 1: Exchange filing cover letter
* cmami limited cmami----- Date: 3rd February, 2022 The ManagerListing - The Manager - Listing The National Exchange of India Stock Ltd. BSE Limited Exchange Plaza, Plot No. C/1, G. Block Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai - 400 051 Mumbai - 400 001 Scrip
Slide 2: Emami continues steady growth
Emami continues steady growth Q3 & 9M revenues grow by 4% and 13% while PAT rises by 5% and 31% respectively Q3FY22 & 9MFY22 HIGHLIGHTS Consolidated Revenues grew by 4% on a high base of 15% growth in previous year; 2 year CAGR 9% o 7% growth excluding Immunity & Hygiene range o Domestic Business
Slide 3: Press release continued: distribution, campaigns, results
outlets increased with coverage expanding to 40 cities and more than 3400 outlets. The Company has also activated more than 26,000 additional outlets for its healthcare products by focusing on Ayurvedic bhandars and chemist outlets During the quarter, the Company launched various TV Commercials for
Slide 4: About Emami Ltd
International Business has also performed well growing by 7% on a year on year basis and by 16% on a 2 year CAGR basis led by Bangladesh and few other regions.” About Emami Ltd Emami: (NSE: EMAMILTD, BSE: 531162) Emami Ltd, founded in 1974, is one of India’s leading FMCG Companies engaged in manufac
Slide 5: Q3 & 9MFY22 Performance Update
Q3 & 9MFY22 Performance Update 3rd February 2022
Slide 6: Revenue Growth
Revenue Growth Growth in Q3FY22 Revenue Split Growth in Q3FY22 Key Financials 9MFY22 Institutional Over PY 2 yr CAGR Over PY 3% • Domestic Business 3% 9% 14% International 15% • International Business 7% 16% 4% • Institutional Business 16% -8% 24% Domestic 82% Consolidated Net Sales 4% 10% 13% • Oth
Slide 7: BoroPlus Range
BoroPlus Range ▹ Sales grew by 2% in Q3; 2 year CAGR of 10% ▸ Lower sales in Q3 due to phasing & pre-loading in Sep’21. ▸ Sep-Dec’21 sales grew by 9% ▸ 8% growth in 9MFY22 ▹ Launched new TVC starring actress Nushrratt Bharuccha for light and non-sticky BoroPlus SOFT Ayurvedic Antiseptic Cream. ▸ Als
Slide 8: Pain Management Range
Pain Management Range ▹ Sales grew by 7% in Q3; 2 year CAGR of 10% ▸ 21% growth in 9MFY22 ▹ Launched geography focused tactical communication TVC’s for Zandu Balm– ▸ North - Creating relevance of smog and steam inhalation during winters ▸ South + West :Chale Chalo campaign with Sonu Sood ▹ Launched
Slide 9: Kesh King Range
Kesh King Range ▹ Sales growth almost flat in Q3; 2 year CAGR of 7% ▸ 17% growth in 9MFY22 ▹ Launched new TVC for Kesh King Oil featuring Shilpa Shetty to widen brand appeal & reach out to a larger TG . ▹ Launched Kesh King Anti Dandruff Shampoo in Oct’21 - before onset of winters, to stay relevant
Slide 10: Navratna Range
Navratna Range ▹ Sales grew by 11% in Q3; 2 year CAGR flat. ▸ 8% growth in 9MFY22 ▹ Launched new campaign in Southern markets with key message – Grandmothers (generations) trust Navratna Oil champi over regular Coconut oil for headache relief because it has 9 Ayurvedic herbs ▸ Launched new Telugu TV
Slide 11: Male Grooming Range
Male Grooming Range ▹ Sales declined by 3% in Q3; 2 year CAGR of 1% ▸ 21% growth in 9MFY22 ▹ Launched eCommerce exclusive Combo pack in Oct’ 21 – containing Fair and Handsome Radiance Cream 60 gm and Fair and Handsome Instant Radiance Face Wash 100gm 7
Slide 12: Healthcare Range
Healthcare Range ▹ Sales declined by 6% in Q3; 2 year CAGR of 14% ▸ Excluding Immunity portfolio, sales grew by 2% in Q3; 2 year CAGR of 21% ▸ 11% growth in 9MFY22 (incl. immunity portfolio) ▹ Roped in Bollywood superstar Ajay Devgn as the face of Zandu Chyawanprash ▸ Digital campaign reached out th
Slide 13: International Business Performance
International Business Performance ▹ Sales grew by 7% in Q3; 2 year CAGR of 16% AFRICA & OTHERS ▸ 14% growth excluding Immunity & Hygiene range 12% CIS ▸ SAARC grew strongly led by Bangladesh 10% SAARC 9MFY22 43% Cluster Wise Contribution ▹ 9MFY22 sales grew by 4% ▸ 10% growth excluding Immunity & H
Slide 14: Ad Campaigns
Ad Campaigns 32a sik Aone ara B Stor At Frere India's 1st Non-Sticky Antiseptic Cream! BOROPLUS } ) AYURVEDIC Antiseptic Cream BOROPLUS — doodh kesar hte pe Kesh King INDIA'S Not HAIR FALL EXPERT
Slide 15: Digital Campaigns
ésmami Digital Campaigns Boro Plus Henthy Skin /@> Ajay Devgn © Stay away from sugar because the ACP ~ Anti Cheeni Police is here. Choose good health with Gur in Zandu's Gurwala Chyavanprash and stay healthy and fit t8harucha #ZanduKaGurwalaChyavanprash #Ad WR theshilpashetty and keshkingofficial Pa
Slide 16: eCommerce Marketing
eCommerce Marketing Kesh King Onion range promoted on Nykaa under their Christmas Deals and Brands you will love section Entered into a Media Barter partnership with Pharmeasy wherein Zandu Ortho Vedic Oil will Partnered with Big Basket on the get prominent visibility on Zandu Participated in Health
Slide 17: BTL Activities
BTL Activities 5 ous nod aNmiseic BRAND fA) a . KUMAR CHEMIST KUMAR CHEMIST
Slide 18: Financial Performance analysis
Financial Performance analysis Earnings analysis for Q3 & 9MFY22 14
Slide 19: Q3FY22 Profitability (Consolidated)
Q3FY22 Profitability (Consolidated) Growth Margin Margin 2 year Q3FY22 Q3FY22 ₹ in crore over Growth over Growth over CAGR Margins Q3FY21 Q3FY21 Q3FY20 Revenues 972 4% 9% Gross Profit 655 0% 9% 67.4% -300 bps -80 bps EBIDTA 342 0% 14% 35.1% -130 bps +270 bps PAT 220 5% 23% 22.6% +20 bps +480 bps Cas
Slide 20: Q3FY22 Financial Analysis
Q3FY22 Financial Analysis Cost of Goods Sold Staff Costs A&P Costs (as a % of sales) (as a % of sales) (as a % of sales) +300 bps -80 bps -30 bps 32.6% 8.2% 16.6% 29.6% 7.4% 16.3% Q3FY21 Q3FY22 Q3FY21 Q3FY22 Q3FY21 Q3FY22 Admin & Other Exp Other Income Interest Paid (as a % of sales) (₹ in Millions)
Slide 21: 9MFY22 Financial Analysis
9MFY22 Financial Analysis Cost of Goods Sold Staff Costs A&P Costs (as a % of sales) (as a % of sales) (as a % of sales) +200 bps -90 bps +40 bps 32.5% 10.8% 15.4% 9.9% 30.5% 15.0% 9MFY21 9MFY22 9MFY21 9MFY22 9MFY21 9MFY22 Admin & Other Exp Other Income Interest Paid (as a % of sales) (₹ in Millions
Slide 22: Q3FY22 Summarized Financials
Q3FY22 Summarized Financials ₹ in Millions Growth Particulars Q3FY22 % Q3FY21 % FY21 % over PY Net Sales 9,605.1 98.8% 9,247.4 99.0% 3.9% 28,542.6 99.1% Other Operating Income 113.4 1.2% 88.7 1.0% 27.8% 262.7 0.9% Revenue from Operations 9,718.5 100.0% 9,336.1 100.0% 4.1% 28,805.3 100.0% Materials C
Slide 23: 9MFY22 Summarized Financials
9MFY22 Summarized Financials ₹ in Millions Growth Particulars 9MFY22 % 9MFY21 % FY21 % over PY Net Sales 23,935.7 98.8% 21,253.5 98.9% 12.6% 28,542.6 99.1% Other Operating Income 280.7 1.2% 244.2 1.1% 14.9% 262.7 0.9% Revenue from Operations 24,216.4 100.0% 21,497.7 100.0% 12.6% 28,805.3 100.0% Mate
Slide 24: Thank You
emami Thank You